|
ARTICLE |
|
Year : 1977 | Volume
: 23
| Issue : 2 | Page : 77-83 |
The place of ethacridine lactate for mid-trimester M.T.P. (Multicentric study)
VN Purandare, Veena Mhatre, Usha R Krishna, SG Gogate, Kusum C Gupta, UK Sheth, Aruna Khatu
Department of Obstetrics & Gynaecology,and Pharmacology, K.E.M Hospital & Seth .G.S.Medical College, Parel, Bombay 400012, India
Correspondence Address:
V N Purandare Department of Obstetrics & Gynaecology,and Pharmacology, K.E.M Hospital & Seth .G.S.Medical College, Parel, Bombay 400012 India
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 614418 
Ethacridine Lactate is a safe abortifacient with about 80% success and hardly any side effects. The incidence of retained placenta is 16%. The extra-amniotic injection is a technically simple procedure and can be carried out even between 13-15 weeks of pregnancy when intraamniotic injection is difficult. Its bactericidal properties minimise the danger o f post-abortal infection. It can be used in certain medical conditions like hypertension, bronchial asthma where hypertonic saline and prostaglandin are contraindicated.
[FULL TEXT] [PDF Not available]*
|